adcelannotate = {"mobilepaywallcategory" : "MOBILE_PREM-BUSINESS","nativepaywallcategory" : "NATIVE_PREM-BUSINESS"};Roxane Laboratories is getting a new owner. London-based Hikma Pharmaceuticals said today that it is buying Roxane from its German owners, Boehringer Ingelheim, for $2.65 billion in cash and stock.